NICE recommends it (Technology Appraisal TA664) for a more restricted population than semaglutide specifically adults with a BMI of 35 kg/m or above (with lower thresholds for certain ethnic groups) who also have prediabetes and a high risk of cardiovascular disease, and only when used within a specialist weight management service
When accuracy matters, the solvent matters
New diets have given way to injections, and the message implicit and sometimes explicit is that the problem of weight has finally been solved
Significant weight reduction can lead to decreased skin elasticity, increased skin laxity, dryness, and subjective changes in skin texture
14.2 Weight Reduction and Long-term Maintenance Studies in Adults with Obesity or Overweight SPL UNCLASSIFIED SECTION Overview of Clinical Trials in Adults The efficacy of WEGOVY once weekly subcutaneous injection for weight reduction and long-term maintenance of body weight in conjunction with a reduced-calorie diet and increased physical activity were studied in three 68-week, randomized, double-blind, placebo-controlled trials
D.MichaelidesM.BalerR